MMJ Analyst Matt Dula on Cronos

Opportunity exits, but many binary risks

Matt Dula joins Michael Martin to discuss the inherent risks in the MMJ space and those particular to Cronos Group (NASDAQ: CRON).

More Marijuana posts

Two things you don’t know about marijuana

Does the High Times IPO have more downside than upside?

Study with our Market Wizards

To learn more about our courses and lessons, go to MartinKronicle.com and subscribe at the top of the page. We’ll follow up with you immediately.

Subscribe

subscribe on itunes

Please note: I reserve the right to delete comments that are offensive or off-topic.